ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,115Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 910

$655K Total Retail Price of All Prescriptions

Rank: 88 out of 910

1,023 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 1,023 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

23% of this provider’s 1,023 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 13,688 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 1,418 1,179 1 2
SIMVASTATIN 1,038 882 2 3
LEVOTHYROXINE SODIUM 831 717 3 1
METFORMIN HCL 753 617 4 6
HYDROCODONE-ACETAMINOPHEN 711 463 S3 5 8
OMEPRAZOLE 694 563 6 5
AMLODIPINE BESYLATE 480 415 7 4
MORPHINE SULFATE ER 393 160 S2 8 52
LOVASTATIN 390 370 9 20
METOPROLOL TARTRATE 372 318 10 7
ATENOLOL 344 317 11 10
GLYBURIDE 306 268 R 12 46
FUROSEMIDE 253 230 13 9
INSULIN SYRINGE 249 179 14 47
PROAIR HFA 214 132 15 40
LANTUS 211 194 16 30
CLONIDINE HCL 210 181 17 51
ALENDRONATE SODIUM 203 189 18 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 202 173 19 44
RANITIDINE HCL 194 113 20 28
ZOLPIDEM TARTRATE 193 158 21 17
HYDROCHLOROTHIAZIDE 189 175 22 12
PRAVASTATIN SODIUM 173 152 23 16
PAROXETINE HCL 162 135 24 50
LOSARTAN POTASSIUM 161 148 25 15
WARFARIN SODIUM 158 146 26 11
GLIPIZIDE 156 153 27 38
TRIAMTERENE-HCTZ 155 141 28 39
GABAPENTIN 154 106 29 13
TERAZOSIN HCL 146 137 30 61
POTASSIUM CHLORIDE 134 115 31 18
ATORVASTATIN CALCIUM 131 112 32 14
OXYCODONE-ACETAMINOPHEN 122 48 S2 33 31
KLOR-CON 10 121 108 34 88
METOPROLOL SUCCINATE 121 119 34 21
ALLOPURINOL 121 116 34 33
ACTONEL 117 114 37 102
NORTRIPTYLINE HCL 111 70 38 183
TRAMADOL HCL 106 63 39 25
FENOFIBRATE 98 78 40 55
ADVAIR DISKUS 98 74 40 45
PANTOPRAZOLE SODIUM 94 90 42 27
CARVEDILOL 90 82 43 36
POLYETHYLENE GLYCOL 3350 87 81 44 104
PLAVIX 85 66 45 53
FLUTICASONE PROPIONATE 85 54 45 23
FLUOXETINE HCL 84 51 47 49
CLOPIDOGREL 78 65 48 35
DIOVAN 75 66 49 34
CITALOPRAM HBR 74 59 50 19
TRAZODONE HCL 74 41 50 37
HUMALOG MIX 75-25 71 52 52 284
FAMOTIDINE 68 54 53 101
ATELVIA 68 62 53 168
IBUPROFEN 67 52 55 75
GEMFIBROZIL 66 54 56 63
OXYCODONE HCL 64 22 S2 57 42
NOVOLOG MIX 70-30 60 36 58 206
NOVOLIN N 57 46 59 216
TAMSULOSIN HCL 57 56 59 29
QUINAPRIL HCL 53 52 61 148
ACETAMINOPHEN-CODEINE 52 37 S3 62 121
DILTIAZEM ER 51 51 63 105
TRIAMTERENE-HYDROCHLOROTHIAZID 51 45 63 152
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.